FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/08/093479 [Registered on: 22/08/2025] Trial Registered Prospectively
Last Modified On: 22/08/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Preventive 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Anjana procedure (Medicine apply in the eye) and Puncture in some points of the eye for Distance Numbers of eye 
Scientific Title of Study   A Randomised clinical study of Vedhana Karma and Akshabeejadi Anjana In Pratham Patalagata Timir.(Myopia -6D) 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dabhi Gautamkumar Pravinsinh 
Designation  PhD Scholar  
Affiliation  G J Patel Institute of Ayurvedic Study and Research 
Address  G J PATEL INSTITUTE OF AYURVEDIC STUDIES & RESEARCH, ADIT CAMPUS, NEW VALLABHA VIDYANAGAR,ANAND

Anand
GUJARAT
388121
India 
Phone  8980231066  
Fax  -  
Email  gautam.dabhi@cvmu.edu.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr.Vimal Panchani  
Designation  Professor  
Affiliation  G J Patel Institute of Ayurvedic Study and Research 
Address  G J PATEL INSTITUTE OF AYURVEDIC STUDIES & RESEARCH, ADIT CAMPUS, NEW VALLABHA VIDYANAGAR, ANAND

Anand
GUJARAT
388121
India 
Phone  9898381314  
Fax  -  
Email  vimalben.panchani@cvmu.edu.in  
 
Details of Contact Person
Public Query
 
Name  Dabhi Gautamkumar Pravinsinh 
Designation  PhD Scholar 
Affiliation  G J Patel Institute of Ayurvedic Study and Research 
Address  G J PATEL INSTITUTE OF AYURVEDIC STUDIES & RESEARCH, ADIT CAMPUS, NEW VALLABHA VIDYANAGAR, ANAND

Anand
GUJARAT
388121
India 
Phone  8980231066  
Fax  -  
Email  gautam.dabhi@cvmu.edu.in  
 
Source of Monetary or Material Support  
GMP Certified Ayurveda Pharmacy Farmers Ayurveda Pharmacy,Thevelapuram,Kollam-691507 Mo-09447144417  
 
Primary Sponsor  
Name  G J PATEL INSTITUTE OF AYURVEDIC STUDIES RESEARCH 
Address  G J PATEL INSTITUTE OF AYURVEDIC STUDIES AND RESEARCH ADIT CAMPUS NEW VALLABHA VIDYANAGAR, ANAND 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrGautamkumar Dabhi  G J Patel Institute of Ayurvedic Study and Research  ShalakyaTantra OPD, Room no.17 at S.G. Patel Ayuvedic Hospital and Maternity Home,New Vallabh Vidyanagar, ANAND
Anand
GUJARAT 
8980231066

gautam.dabhi@cvmu.edu.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Enstitutionalethicscommittee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:H531||Subjective visual disturbances. Ayurveda Condition: TIMIRAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-vedhana-karma, वेधन-कर्म (Procedure Reference: SU.SHA.8/17, Procedure details: Total Duration of Procedure 3weeks per weeks 3 sittings Alternate days)
2Comparator ArmProcedure-a~jjanam, अंजनम् and Vedhana Karma (Procedure Reference: A.H.U.13/43)(SU.SHA.8/17), Procedure details: Procedure details: Vedhana karma & Akshabeejadi Anjana for 3 weeks same day both procedure done for 3 weeks alternate days)
3Comparator ArmProcedure-a~jjanam, अंजनम् (Procedure Reference: A.H.U.13/43, Procedure details: Total Duration of Procedure 3weeks per weeks 3 sittings Alternate days)
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  30.00 Year(s)
Gender  Both 
Details  Patients with complaints of Prathama Patalagata Timir (Myopia less than -6) 
 
ExclusionCriteria 
Details  Patient having diseases of Corneal, Choroid, Vitreous, retinal, and ciliary muscle
contraindicated for Vedhana karma and Anjana
Systemic diseases like DM, Hypertension, Trauma, etc.
Patient is on medication for a blood thinner  
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To study the etiopathology of Prathama Patalagata Timir in Ayurveda and Modern. during 3 weeks
To evaluate the effect of Vedhana Karma in Prathama Patalagata Timir (Myopia -6D) 
Vedhana Karma and Akshabeejadi Anjana is effective in Prathama Patalagata Timir
observ effect of procedure after 3 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Equally, Effective Anjana and Vedhana Karma in Prathama Patalagata Timir  49 days 
 
Target Sample Size   Total Sample Size="138"
Sample Size from India="138" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   10/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="1"
Days="19" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report
    Response -  Analytic Code

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - Any purpose.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [gautam.dabhi@cvmu.edu.in].

  6. For how long will this data be available start date provided 01-12-2024 and end date provided 31-07-2026?
    Response - Beginning 3 months and ending 5 years following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary  

Introduction:

Acharya Sushruta describes six patala in Netra in which 2 Bahya vartma patala and 4 patala in netra - tejo Jalashrita, Pishitashrita, medoashrita, and last Ashtiashrita, dosha enters in 1st and 2nd patala it’s called Timir.

Dalhana described, Tejo-jalashrita patala Teja means alochaka pitta situated in siragata rakta, jala means twachagata rasa dhatu.

According to Acharya Sushruta Timir causing dosha when reach internal orbital organs through the sira and occupies pratahama patala causing blurring of vision, pratahama patalagata timira vitiates the superficial dhatu.

Acharya Sushruta has mentioned Vedhana karma one of the Ashtvidha shastra karma. Here the meaning of Viddha or Vedhana – is to pierce or penetrate something.

Acharya Vagbhat Describe Anjana types, form, matra, kal and according to dosha use of Anjana karma in sutra sthana chapter 23.

For all types of Timir Acharya Vagbhat describe Akshabeejadi Anjana in Uttartantra.

According to a study by NCBI, the prevalence of myopia in India varies between 3.6% and 36.5% depending on the type of study. Population-based studies have a prevalence rate of 3.6% to 36.5%, while school-based studies have a rate of 7.5% to 8.6%, and hospital-based studies have a rate of 9%. Most of these studies include people under the age of 40.

Myopia, commonly referred to as short-sightedness, is the most common eye disease in the world with a substantial social, educational, and economic impact on the affected one.

Simple myopia can be corrected with spectacles or contact lenses, whereas pathological myopia is often associated with potentially blinding conditions such as retinal detachment or macular degeneration.

Origin of the Research Problem:

 In modern science, the best option for myopia is wearing glasses or contact lens for myopia.

Another option is LASIK surgery but light sensitivity develops after LASIK surgery complications like Dry eye.

So, we can search for alternative medicine Vedhana karma comparison with Akshabeejadi Anjana and add on effect of Vedhana Karma.

 Key Questions:

 1. Only Vedhana karma is Effective in Prathama Patalagata Timir (Myopia <-6D)

2. Only Akshabeejadi Anjana is effective in Prathama Patalagata Timir (Myopia <-6D) 

3. Add-on effect of Vedhana karma with Akshabeejadi Anjana more effective in Prathama Patalagata Timir (Myopia <-6D)

Hypothesis:

Null hypothesis (H0)

Vedhana karma and Akshabeejadi Anjana have no significant effect in Prathama Patalagata Timir (Myopia <-6D)

 Alternative hypothesis (Ha)

 Vedhana karma and Akshabeejadi Anjana having significant effect in Prathama Patalagata Timir (Myopia <-6D)

Objectives:

 

Primary

1.         To study the etiopathology of Prathama Patalagata Timir in Ayurveda and Modern.

2.         To evaluate the effect of Vedhana Karma in Prathama Patalagata Timir (Myopia -<6D)

Secondary

1.         To evaluate the effect of Akshabeejadi Anjana in Prathama Patalagata Timir (Myopia -<6D)

2.         To evaluate the effect of Vedhana Karma with Akshabeejadi Anjana in Prathama Patalagata Timir (Myopia -<6D).

 Research Gap/Review of Literature (International Status/National Status and scope of the proposal):

The treatment of myopia (comparable to Prathama Patalagata Timira) has undesirable aspects such as the permanent use of spectacles.

Akshabeejadi Anjana is one of the effective treatments of Timir.

Vedhana karma, despite being simple and easy to do, remains unexplored in this condition.

Methodology:

Study design - Open Labelled Randomized Comparative Clinical Study.

Group A Vedhana karma

Group B Akshabeejadi Anjana

Group C Vedhana karma & Akshabeejadi Anjana

Sample size total – 138 (Each group 46 Patients Group A 46, Group B 46 and Group C 46)

 

Inclusive criteria

Patients with myopia < -6D in at least one eye, diagnosed as per ICD-10-CM Diagnosis Code H52.1 & H52.2 (Simple myopic astigmatism)

Age 18-30 years

Both Gender

 

Exclusive criteria

 Myopia >-6D

Patient having diseases of Corneal, Choroid, Vitreous, retinal and ciliary muscle

Contraindicated for Vedhana Karma and Anjana

Systemic diseases like DM, Hypertension, Trauma, etc.

Patient is on medication for a blood thinner 

 
Close